The Young Women's Breast Cancer Study

Description

The investigators are conducting a longitudinal cohort study of young women with breast cancer. The investigators identify women age 40 and younger with newly-diagnosed breast cancer from academic and community healthcare institutions. After women consent to the study, they fill-out surveys and give blood samples, and the investigators collect tissue from their breast cancer tumor after it is removed. Women are surveyed every 6 months for the first 3 years after diagnosis, then yearly thereafter for an additional 7 years (for a total follow-up of at least 10 years following diagnosis). The study investigates short and long-term disease and treatment issues, tumor biology and the relationship to patient outcomes, and psychosocial concerns at baseline and in follow-up among a cohort of young women who are newly-diagnosed with breast cancer.

Study Start Date

November 2006

Estimated Completion Date

January 2026

Interventions

No interventions cited

Specialties

  • Obstetrics & Gynecology: Breast
  • Family Medicine: Women`s Health
  • Oncology: Breast
  • Physician Assistant: Women`s Health

MeSH Terms

  • Breast Neoplasms

Study ID

Dana-Farber Cancer Institute -- 06-169

Status

Recruiting

Trial ID

NCT01468246

Study Type

Observational

Trial Phase

N/A

Enrollment Quota

1300

Sponsor

Dana-Farber Cancer Institute

Inclusion Criteria

  • Female
  • Diagnosis of breast cancer
  • Age 40 or younger at diagnosis
  • Informed consent obtained from patient
  • Ability to understand written and spoken English to the extent necessary to complete the questionnaires

Exclusion Criteria

  • Inability to understand written and spoken English to the extent necessary to complete the questionnaires
  • Absence of informed consent

Gender

Female

Ages

18 Years to 40 Years

Accepts Healthy Volunteers

No

Study Locations and Contact Information (21)

Study Location Distance Name Phone Email
DanaFarber Cancer Institute - Boston, Massachusetts 2.4 miles None None None
DanaFarber Cancer Institute - Boston, Massachusetts 2.4 miles Meghan E Meyer BS 617-632-4983 mmeyer1@partners.org
Massachusetts General Hospital - Boston, Massachusetts 2.4 miles Lily Davis 617-726-1923 ldavis22@partners.org
BethIsrael Deaconess Medical Center - Boston, Massachusetts 2.4 miles None None None
Massachusetts General Hospital - Boston, Massachusetts 2.4 miles None None None
South Shore Hospital - South Weymouth, Massachusetts 4.5 miles Patti Nestor 781-624-4788 pnestor@partners.org
South Shore Hospital - South Weymouth, Massachusetts 4.5 miles None None None
NewtonWellesley Hospital - Newton, Massachusetts 4.7 miles Judith Chow 617-243-6392 jgchow@partners.org
NewtonWellesley Hospital - Newton, Massachusetts 4.7 miles None None None
MGHNorth Shore Cancer Center - Danvers, Massachusetts 16.4 miles Rosemary Stankiewicz 978-882-6044 rstankiewicz@mgh.harvard.edu
MGHNorth Shore Cancer Center - Danvers, Massachusetts 16.4 miles None None None
Lowell General Hospital - Lowell, Massachusetts 23.0 miles None None None
Lowell General Hospital - Lowell, Massachusetts 23.0 miles Stephanie ValcourtDexter CCRC 978-788-7227 None
DFBWCC at Milford Regional Medical Center - Milford, Massachusetts 26.3 miles Maureen Patrick 508-488-3718 Maureen_Patrick@dfci.harvard.edu
DFBWCC at Milford Regional Medical Center - Milford, Massachusetts 26.3 miles None None None
DanaFarberNew Hampshire OncologyHematology - Londonderry, New Hampshire 37.5 miles None None None
Cape Cod Hospital - Hyannis, Massachusetts 64.6 miles None None None
Mayo Clinic - Rochester, Minnesota 1,083.1 miles Jessica Edge 507-266-3867 Edge.Jessica@mayo.edu
Mayo Clinic - Rochester, Minnesota 1,083.1 miles None None None
University of Colorado Cancer Center - Aurora, Colorado 1,759.8 miles Kari Anderson BA 720-848-8031 Kari.Anderson@ucdenver.edu
University of Colorado Cancer Center - Aurora, Colorado 1,759.8 miles None None None

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.